Oxford Molecular: designer appeal
Article Abstract:
Oxford Molecular is a UK company licenses software used to design and test new products for the pharmaceutical industry, and has been affected by investors' disenchantment with UK biotech companies. The company should benefit from the acquisition of IntelliGenetics, a US firm, for 5 million pounds sterling in Aug 1994. The company sells technology to large drug firms, and also aims to boost revenue by performing tests for small drug firms on a contract basis. Oxford has promising potential for growth and the company's shares are recommended for investment.
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 1995
User Contributions:
Comment about this article or add new information about this topic:
Overdose of hype at ML Labs
Article Abstract:
ML Laboratories is a UK medical products concern which has seen a rise in its share price in 1995, despite having reported losses over ten years of existence. The company's shares rose after reports of a successful HIV drug in 1995. The methods of the study have been questioned, and the results are based on only four patients. ML has other products such as Icodial, a kidney dialysis fluid, but the company is involved in legal action with Baxter over this product.
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 1996
User Contributions:
Comment about this article or add new information about this topic:
Healthcare looks buoyant
Article Abstract:
Opportunities for investors in the healthcare sector are examined in detail, and the sector is seen as offering good growth prospects.
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Gene targeting using zinc finger nucleases. The small world of metabolism. Electrochemical DNA analysis comes of age
- Abstracts: Brave new world. Euro defence closes the gap. Aerospace, defence
- Abstracts: How to be an oil tycoon. Caspian deal comes with snags. Oil exploration
- Abstracts: The information superhighway: establishing your nexus. Databases: is there one in your practice management future?
- Abstracts: Better focus boosts prospects. Micro Focus. IS Solutions